Latest PharmaceuticalIndustry News and Updates : PharmaceuticalIndustry updates, PharmaceuticalIndustry News , PharmaceuticalIndustry around the world

Nishadil

Washington | 12°C (overcast clouds)

Veeva Systems' Quiet Triumph: Secures Another Top Biopharma Giant

Top story

Veeva Systems' Quiet Triumph: Secures Another Top Biopharma Giant

In focus

Latest feed

The Bodega Peptide Scam: What Lab Tests Revealed About Those Tiny Vials

Zamorin Raja P.K. Kerala Varma, Veteran Pharmacologist, Passes Away at 89

Zamorin Raja P.K. Kerala Varma Passes Away at 89

Biotech M&A Fever: Eli Lilly's Bold Bets Spark Retail Trader Excitement for Sellas and ImmunityBio

Latest headlines

Federal Court Blocks Overseas Drug Imports, Upholding Gilead's Stance on Patient Safety and FDA Oversight

Federal Court Blocks Overseas Drug Imports, Upholding Gilead's Stance on Patient Safety and FDA Oversight

Teva's Strategic Pivot Gains Traction: Innovative Growth Offsets Generics Slide in Q2 2026

Teva's Strategic Pivot Gains Traction: Innovative Growth Offsets Generics Slide in Q2 2026

A $10 Billion Shake-Up: Vertex Pharmaceuticals to Acquire Crinetics in Major Cash Deal

A $10 Billion Shake-Up: Vertex Pharmaceuticals to Acquire Crinetics in Major Cash Deal

A Bipartisan Push? Republican Lawmakers Tackle Clinical Trial Diversity

A Bipartisan Push? Republican Lawmakers Tackle Clinical Trial Diversity

The Capitol's Pulse: When Wellness Met Wealth, and Big Pharma Prevailed

The Capitol's Pulse: When Wellness Met Wealth, and Big Pharma Prevailed

A New Dawn: Roche's Landmark Drug Redefines Hope for KRAS-Driven Lung Cancer Patients

A New Dawn: Roche's Landmark Drug Redefines Hope for KRAS-Driven Lung Cancer Patients

A President's Pledge: RFK Jr. Vows to Revoke All COVID-19 Emergency Use Authorizations

A President's Pledge: RFK Jr. Vows to Revoke All COVID-19 Emergency Use Authorizations

AstraZeneca's Texas Tangle: Unpacking the Kickback Settlement

AstraZeneca's Texas Tangle: Unpacking the Kickback Settlement

The High-Stakes Battle: Why Pharmacy Benefit Managers Are Fighting Tooth and Nail

The High-Stakes Battle: Why Pharmacy Benefit Managers Are Fighting Tooth and Nail

AbbVie’s $11 Billion Bet on Cancer Innovation

AbbVie’s $11 Billion Bet on Cancer Innovation

India Takes a Stand: 16 Drug Combinations Banned for Patient Safety

India Takes a Stand: 16 Drug Combinations Banned for Patient Safety

Africa's Bold Vision: Taking Control of Its Vaccine Future

Africa's Bold Vision: Taking Control of Its Vaccine Future

India's Cough & Cold Syrup Shake-Up: What the OTC Ban Means for You and the Market

India's Cough & Cold Syrup Shake-Up: What the OTC Ban Means for You and the Market

The Weight of Progress: Employers Grapple with GLP-1 Costs and Coverage

The Weight of Progress: Employers Grapple with GLP-1 Costs and Coverage

Gujarat Themis Biosyn's Rs 1,300 Crore Coup: A Strategic Leap into Global API Dominance

Gujarat Themis Biosyn's Rs 1,300 Crore Coup: A Strategic Leap into Global API Dominance

The Quiet Influence: Pharma's Play in Shaping Policy

The Quiet Influence: Pharma's Play in Shaping Policy

The Great Generic Drug Revolution: Mark Cuban, 'TrumpRx,' and the Fight for Affordable Medicine

The Great Generic Drug Revolution: Mark Cuban, 'TrumpRx,' and the Fight for Affordable Medicine

Supreme Court Takes Up the Fight Over Medicare Drug Price Negotiations

Supreme Court Takes Up the Fight Over Medicare Drug Price Negotiations

Supreme Court Weighs the Future of Medicare Drug Price Negotiations

Supreme Court Weighs the Future of Medicare Drug Price Negotiations

Supreme Court Weighs In on Medicare's Push to Bargain for Prescription Drug Prices

Supreme Court Weighs In on Medicare's Push to Bargain for Prescription Drug Prices

Supreme Court’s Decision Keeps Medicare Drug Price Cuts in Place

Supreme Court’s Decision Keeps Medicare Drug Price Cuts in Place

The Pharmaceutical Frontier: Biosimilars on the Rise

The Pharmaceutical Frontier: Biosimilars on the Rise

Ivermectin's Unfulfilled Promise: A Potential Cancer Drug Quashed

Ivermectin's Unfulfilled Promise: A Potential Cancer Drug Quashed

The Unraveling of Kezar Life Sciences: How an FDA Delay Triggered a Biotech Startup's Collapse

The Unraveling of Kezar Life Sciences: How an FDA Delay Triggered a Biotech Startup's Collapse

Global Tensions Squeeze Indian Pharma: Rising Raw Material Costs a Growing Concern

Global Tensions Squeeze Indian Pharma: Rising Raw Material Costs a Growing Concern

Remembering Trump's Bold Move: The 100% Tariff Threat on Pharmaceuticals

Remembering Trump's Bold Move: The 100% Tariff Threat on Pharmaceuticals

Takeda Announces Significant Job Cuts, Centered on Cambridge R&D

Takeda Announces Significant Job Cuts, Centered on Cambridge R&D

A Child's Battle, An Insurance Denial: Mark Cuban Highlights Healthcare's Heartbreaking Flaws

A Child's Battle, An Insurance Denial: Mark Cuban Highlights Healthcare's Heartbreaking Flaws

The Drumbeat Builds: Milestone Pharma Prepares for Q4 Earnings Reveal

The Drumbeat Builds: Milestone Pharma Prepares for Q4 Earnings Reveal

A Game-Changer: Boost Pharma Welcomes Biotech Visionary Elaine Jones as New Board Chair

A Game-Changer: Boost Pharma Welcomes Biotech Visionary Elaine Jones as New Board Chair

The Persistent Echo: Trump's Most Favored Nation Policy Still Shapes Drug Pricing Debates

The Persistent Echo: Trump's Most Favored Nation Policy Still Shapes Drug Pricing Debates

The Future of Medicine: Unlocking Potential with Organoids and Spheroids

The Future of Medicine: Unlocking Potential with Organoids and Spheroids

A Wake-Up Call for Big Pharma: FDA Cracks Down on Novo Nordisk

A Wake-Up Call for Big Pharma: FDA Cracks Down on Novo Nordisk

The Maverick Doctor Poised to Redefine Public Health in America

The Maverick Doctor Poised to Redefine Public Health in America

The Shadow of Geopolitics: Indian Pharma Exports to Middle East Face Uncertainty Amidst Rising Tensions

The Shadow of Geopolitics: Indian Pharma Exports to Middle East Face Uncertainty Amidst Rising Tensions

The Price of Life: Will South Africa Gain Access to Gilead's Breakthrough HIV Drug?

The Price of Life: Will South Africa Gain Access to Gilead's Breakthrough HIV Drug?

Virginia's Bold Move: A New Era for Prescription Drug Affordability

Virginia's Bold Move: A New Era for Prescription Drug Affordability

A Hard-Won Victory: Henrietta Lacks' Estate Secures Settlement with Novartis

A Hard-Won Victory: Henrietta Lacks' Estate Secures Settlement with Novartis

Load more